GlassScriptPhysician profile
Ted Victor Jacoby
NPI 1306520374
$1,895.03
in general payments reported to CMS, 2019-2025
9 companies · $1,202 in 2025
The $1,202 reported for 2025 was more than what 87% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $30.05 · 2024: $663 · 2025: $1,202.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,895.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,895.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $397.89 | 2023-2025 | Dupixent |
| Ucb, INC. | $282.35 | 2025 | Bimzelx |
| Janssen Scientific Affairs, LLC | $267.84 | 2024-2025 | Tremfya |
| Sun Pharmaceutical Industries INC. | $251.18 | 2024-2025 | |
| Genzyme Corporation | $197.62 | 2025 | |
| Galderma Laboratories, L.P. | $141.44 | 2024 | |
| Arcutis Biotherapeutics, INC. | $137.41 | 2025 | Zoryve |
| Lilly USA, LLC | $113.89 | 2025 | Ebglyss |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $105.41 | 2025 | Cabtreo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ted Jacoby listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.